News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,758 Results
Type
Article (88946)
Company Profile (555)
Press Release (796238)
Multimedia
Podcasts (245)
Webinars (36)
Section
Business (267067)
Career Advice (4164)
Deals (40026)
Drug Delivery (181)
Drug Development (91784)
Employer Resources (208)
FDA (18603)
Job Trends (17498)
News (398899)
Policy (40023)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (60)
ADA (49)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (243)
Alzheimer's disease (2032)
Antibody-drug conjugate (ADC) (592)
Approvals (18999)
Artificial intelligence (921)
ASCO (345)
Autoimmune disease (384)
Automation (70)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (261)
Biotechnology (336)
Bladder cancer (218)
Brain cancer (86)
Breast cancer (862)
Cancer (6821)
Cardiovascular disease (575)
Career advice (3601)
Career pathing (53)
CAR-T (395)
CDC (77)
Celiac Disease (3)
Cell therapy (1111)
Cervical cancer (58)
Clinical research (79411)
Collaboration (2477)
Commercialization (1)
Company closure (8)
Compensation (1596)
Complete response letters (115)
COVID-19 (3046)
CRISPR (130)
C-suite (1369)
Cystic fibrosis (170)
Data (9030)
Decentralized trials (3)
Denatured (94)
Depression (205)
Dermatology (105)
Diabetes (731)
Diagnostics (7654)
Digital health (73)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (465)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (335)
Earnings (102580)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139024)
Executive appointments (1232)
FDA (22892)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2027)
Gene editing (285)
Generative AI (93)
Gene therapy (876)
GLP-1 (1300)
Government (5571)
Grass and pollen (8)
Guidances (426)
Healthcare (21277)
Hematology (198)
HIV (100)
Huntington's disease (72)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (120)
Immunology and inflammation (368)
Immuno-oncology (122)
Indications (227)
Infectious disease (3458)
Inflammatory bowel disease (247)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (334)
Interviews (822)
IPO (18014)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (127)
Layoffs (696)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (901)
Lymphoma (493)
Machine learning (70)
Management (68)
Manufacturing (1309)
Marketing (7)
MASH (232)
Medical affairs (1)
Medical device (15313)
Medtech (15506)
Mergers & acquisitions (23372)
Metabolic disorders (1883)
mRNA (281)
Multiple sclerosis (214)
NASH (24)
Neurodegenerative disease (542)
Neuropsychiatric disorders (133)
Neuroscience (3861)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (84)
Obesity (892)
Opinion (382)
Ovarian cancer (252)
Pain (293)
Pancreatic cancer (376)
Parkinson's disease (432)
Partnered (43)
Patents (690)
Patient recruitment (830)
Peanut (72)
People (68220)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24537)
Phase 2 (34495)
Phase 3 (25936)
Pipeline (10433)
Policy (406)
Postmarket research (3561)
Preclinical (11007)
Press Release (72)
Prostate cancer (358)
Psychedelics (75)
Radiopharmaceuticals (382)
Rare diseases (1343)
Real estate (7463)
Recruiting (82)
Regulatory (30718)
Reports (78)
Research institute (2777)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (347)
Series B (252)
Service/supplier (15)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (148)
Vaccines (1338)
Venture capital (143)
Weight loss (607)
Women's health (147)
Worklife (25)
Date
Today (118)
Last 7 days (453)
Last 30 days (2143)
Last 365 days (33289)
2026 (18383)
2025 (33215)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1298)
Alabama (103)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52462)
Australia (9219)
California (14737)
Canada (4146)
China (1662)
Colorado (634)
Connecticut (651)
Delaware (453)
Europe (120987)
Florida (2219)
Georgia (479)
Hawaii (4)
Idaho (70)
Illinois (1290)
India (110)
Indiana (677)
Iowa (25)
Japan (629)
Kansas (144)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1768)
Massachusetts (10782)
Michigan (427)
Minnesota (819)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (158)
New Hampshire (92)
New Jersey (3902)
New Mexico (35)
New York (3897)
North Carolina (1952)
North Dakota (11)
Northern California (7362)
Ohio (459)
Oklahoma (28)
Oregon (46)
Pennsylvania (2887)
Puerto Rico (33)
Rhode Island (53)
South America (1670)
South Carolina (91)
South Dakota (2)
Southern California (5814)
Tennessee (241)
Texas (2392)
United States (52626)
Utah (442)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1195)
West Virginia (4)
Wisconsin (159)
Wyoming (2)
There are 885,758 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
FDA proposes streamlined requirements for ‘hub-and-spoke’ manufacturing models
Through the proposal, the FDA could clear barriers to distributed manufacturing approaches intended to enhance emergency preparedness and supply chain resilience.
July 14, 2026
·
2 min read
·
Nick Paul Taylor
Alzheimer’s disease
Biogen, Eisai win FDA nod for starter dose of subcutaneous Leqembi
Leqembi Iqlik can now be given at home throughout the entire course of treatment, setting it apart from Eli Lilly’s Kisunla, the only other anti-amyloid Alzheimer’s disease therapy on the market.
July 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.
July 14, 2026
·
9 min read
Press Releases
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
July 14, 2026
·
4 min read
Press Releases
Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer
July 14, 2026
·
5 min read
Press Releases
Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus
July 14, 2026
·
7 min read
Press Releases
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10
July 14, 2026
·
4 min read
Press Releases
Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026
July 14, 2026
·
6 min read
Press Releases
Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
July 14, 2026
·
3 min read
Press Releases
InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL
July 14, 2026
·
3 min read
1 of 88,576
Next
